Bastian Erb, director production engineering, Vetter, shares insights into how robotics and automation — including innovations like the Syringe Speed Picker — are transforming pharmaceutical manufacturing.
Symbiosis Pharmaceutical Services (Symbiosis) has completed qualification of its new FPD 50 Flexicon automated fill/finish line at its new commercial production facility in Stirling, Scotland.
In this article, Jim Donovan, general manager for Pfizer CentreOne, explores the concept of “lightspeed” development under high-pressure situations, such as pandemics and drug shortages.
Steriline will exhibit for the second consecutive year at Pharma Pro&Pack Expo, an important trade show in India dedicated to machinery for the treatment and packaging of products in the pharmaceutical and biotechnological sectors.
Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), has announced progress on its new sterile manufacturing facility, scheduled to open in early 2026.
PCI Pharma Services will use the BIO International Convention, 16-19th June in Boston, as a platform to introduce its new purpose-built facility for large-scale sterile fill-finish operations at its campus in nearby Bedford, NH.
Azenta Life Sciences announce a new range of Electron-Beam (E-Beam) treated externally threaded tubes, expanding options for laboratories and biorepositories that desire sterile sample storage solutions.
August 2025 marks two years since revisions to Annex 1 of the European Union’s Good Manufacturing Practice (GMP) guidelines were introduced. Niamh Bissett, director, business transformation at West Pharmaceutical Services discusses.
PCI Pharma Services – a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea.
